More from Curaleaf

Cannabis European

Cannabis in Europe faces many regulatory challenges

Europe’s medicinal cannabis market has been growing steadily in the past three years and we continue to work hard with regulators and governments across Europe to accelerate access for patients.

We are at the forefront of scientific innovation and have established research partnerships with world-renowned institutions. These partnerships are designed to provide more clinical data to under-pin the growing cannabis market worldwide – supporting better access for all.

Cannabis is not created equally

The difference between medical grade cannabis and unregulated CBD is vast. We are able to produce quality, medical grade cannabis thanks to our vertically integrated supply chain. Tightly controlled at every point in the production process, our supply chain is designed to ensure reliability and consistency, batch after batch.

Explore Curaleaf International cannabis

You are about to leave the Curaleaf International website.